Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani

Visceral leishmaniasis (VL) is associated with treatment complications due to the continued growth of resistant parasites toward currently available pathogen-directed therapeutics. To limit the emergence and combat resistant parasites there is a need to develop new anti-leishmanial drugs and alterna...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Parasitol Drugs Drug Resist
Autores principales: Zahid, M. Shamim Hasan, Johnson, Monica M., Tokarski, Robert J., Satoskar, Abhay R., Fuchs, James R., Bachelder, Eric M., Ainslie, Kristy M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731340/
https://ncbi.nlm.nih.gov/pubmed/31493763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2019.08.004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares